首页> 中文期刊> 《中国生化药物杂志》 >消癌平注射液联合FOLFOX6方案化疗在晚期胃癌治疗与干预效果分析

消癌平注射液联合FOLFOX6方案化疗在晚期胃癌治疗与干预效果分析

         

摘要

Objective To explore the treatment for patients with advanced gastric cancer, the use of xiaoaiping injection combined with FOLFOX6 chemotherapy intervention. Methods 40 cases of patients with advanced gastric cancer for the implementation of FOLFOX6 chemotherapy intervention, at the same time as the control group, the other 40 patients in the control group based on the use of xiaoaiping injection, and classified as the observation group, two groups of patients were in our hospital from March 2015 to January 2017 . Results Comparing the two groups of patients with the treatment efficiency, the patients in the observation group were higher obviously; the observation group patients nursing satisfaction rate was significantly higher (P<0.05) shows significant differences. Compared two groups of patients with adverse reactions, found in the two groups were different, but the difference was not obvious. Conclusion The visible analysis of the effect of xiaoaiping injection combined with FOLFOX6 chemotherapy in the treatment of advanced gastric cancer, compared with chemotherapy and intervention The utility model has the advantages that the patient can be improved in time, and the clinical treatment effect can be improved, so that the utility model is worthy of clinical reference.%目的 探究在晚期胃癌治疗时,使用消癌平注射液联合FOLFOX6方案化疗干预的效果.方法 针对40例晚期胃癌患者实施FOLFOX6方案化疗干预,同时归为对照组,针对另外40例患者在对照组基础上使用消癌平注射液,并归为观察组,2组患者均为本院2015年3月~2017年1月间收治.结果 比较2组患者的治疗有效率,明显可见观察组患者较高;观察组患者的护理满意率明显较高(P<0.05).比较2组患者的不良反应情况,发现2组患者均存在一定差异,但其差异均不明显.结论 消癌平注射液联合FOLFOX6方案化疗在晚期胃癌治疗中的效果分析可见,其相比单纯的化疗干预而言,能够使得患者情况得到及时改善,提高临床治疗效果.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号